Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,268 Cr
down ₹154 Cr vs Jan 2023
- Stocks held
- 29
- down 1 vs Jan 2023
- Top 10 weight
- 62.8%
- of the portfolio in its ten largest
- Cash & debt
- 0.8%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 17
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In February 2023 it disclosed 29 stocks worth ₹4,268 Cr, down ₹154 Cr from Jan 2023. Its largest positions were Sun Pharmaceutical Industries Limited (14.7%), Dr. Reddy's Laboratories Limited (8.1%), Lupin Limited (6.8%); the ten largest together made up 62.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.8% of its equity. Cash and debt stood at 0.8%. Compared with Jan 2023 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
11%
Holds more cash than 11% of peers
Holdings in February 2023
Download CSVEvery line the fund disclosed, with the change against Jan 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.70%
- Δ weight
- down 0.64 pts
- Value
- ₹627 Cr
- Δ value
- down ₹51.1 Cr
- Status
- Trimmed
- Weight
- 8.09%
- Δ weight
- down 0.19 pts
- Value
- ₹345 Cr
- Δ value
- down ₹20.9 Cr
- Status
- Trimmed
- Weight
- 6.80%
- Δ weight
- down 0.70 pts
- Value
- ₹290 Cr
- Δ value
- down ₹41.5 Cr
- Status
- Trimmed
- Weight
- 6.37%
- Δ weight
- down 0.53 pts
- Value
- ₹272 Cr
- Δ value
- down ₹33.5 Cr
- Status
- Trimmed
- Weight
- 5.37%
- Δ weight
- up 0.36 pts
- Value
- ₹229 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 5.23%
- Δ weight
- up 0.34 pts
- Value
- ₹223 Cr
- Δ value
- up ₹6.8 Cr
- Status
- Added
- Weight
- 4.33%
- Δ weight
- down 0.49 pts
- Value
- ₹185 Cr
- Δ value
- down ₹28.5 Cr
- Status
- Trimmed
- Weight
- 4.30%
- Δ weight
- down 0.57 pts
- Value
- ₹184 Cr
- Δ value
- down ₹31.8 Cr
- Status
- Trimmed
- Weight
- 3.80%
- Δ weight
- up 0.56 pts
- Value
- ₹162 Cr
- Δ value
- up ₹19.1 Cr
- Status
- Added
- Weight
- 3.77%
- Δ weight
- up 0.40 pts
- Value
- ₹161 Cr
- Δ value
- up ₹11.8 Cr
- Status
- Added
- Weight
- 3.77%
- Δ weight
- down 0.02 pts
- Value
- ₹161 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- Weight
- 3.45%
- Δ weight
- down 0.06 pts
- Value
- ₹147 Cr
- Δ value
- down ₹7.9 Cr
- Status
- Trimmed
- Weight
- 3.25%
- Δ weight
- down 0.06 pts
- Value
- ₹139 Cr
- Δ value
- down ₹7.5 Cr
- Status
- Trimmed
- Weight
- 3.09%
- Δ weight
- up 0.15 pts
- Value
- ₹132 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 3.05%
- Δ weight
- up 0.28 pts
- Value
- ₹130 Cr
- Δ value
- up ₹7.7 Cr
- Status
- Added
- Weight
- 2.79%
- Δ weight
- up 0.03 pts
- Value
- ₹119 Cr
- Δ value
- down ₹2.8 Cr
- Status
- Trimmed
- Weight
- 2.61%
- Δ weight
- up 0.04 pts
- Value
- ₹111 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 2.48%
- Δ weight
- down 0.13 pts
- Value
- ₹106 Cr
- Δ value
- down ₹9.7 Cr
- Status
- Trimmed
- Weight
- 2.10%
- Δ weight
- up 0.18 pts
- Value
- ₹89.7 Cr
- Δ value
- up ₹4.6 Cr
- Status
- Added
- Weight
- 1.87%
- Δ weight
- down 0.36 pts
- Value
- ₹79.8 Cr
- Δ value
- down ₹18.7 Cr
- Status
- Trimmed
- Weight
- 1.60%
- Δ weight
- up 0.41 pts
- Value
- ₹68.5 Cr
- Δ value
- up ₹15.6 Cr
- Status
- Added
- Weight
- 1.54%
- Δ weight
- up 0.18 pts
- Value
- ₹65.9 Cr
- Δ value
- up ₹5.8 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- down 0.02 pts
- Value
- ₹56.6 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 1.09%
- Δ weight
- up 0.86 pts
- Value
- ₹46.6 Cr
- Δ value
- up ₹36.5 Cr
- Status
- Added
- Weight
- 0.91%
- Δ weight
- up 0.13 pts
- Value
- ₹39 Cr
- Δ value
- up ₹4.5 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.78%
- Δ weight
- up 0.08 pts
- Value
- ₹33.4 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 0.56%
- Δ weight
- up 0.06 pts
- Value
- ₹24.1 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 0.39%
- Δ weight
- down 0.04 pts
- Value
- ₹16.8 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 0.31%
- Δ weight
- down 0.04 pts
- Value
- ₹13.2 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.26%
- Δ weight
- up <0.01 pts
- Value
- ₹11.2 Cr
- Δ value
- down ₹19 L
- Status
- Trimmed
What changed, Jan 2023 to Feb 2023
New New positions (0)
None.
Exited Exited (1)
- Global Health Limitedwas 0.2% · ₹9 Cr
Added Biggest additions
- Syngene International Limitedup ₹36.5 Cr (+0.86% pts)
- Aurobindo Pharma Limitedup ₹19.1 Cr (+0.56% pts)
- MedPlus Health Services Limitedup ₹15.6 Cr (+0.41% pts)
- Zydus Lifesciences Limitedup ₹11.8 Cr (+0.40% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2023, the weight rose most in Healthcare Services (+0.8 pts) and Retailing (+0.4 pts), and fell most in Pharmaceuticals & Biotechnology (−1.4 pts).
- Healthcare Services18.9% → 19.7%+0.8 pts
- Retailing1.2% → 1.6%+0.4 pts
- Pharmaceuticals1.4% → 1.6%+0.2 pts
- Pharmaceuticals & Biotechnology78.2% → 76.8%−1.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2020 | Feb 2022 | Aug 2022 | Nov 2022 | Jan 2023 | Feb 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.2% | 75.8% | 80.6% | 78.5% | 78.2% | 76.8% |
| Healthcare Services | 20.8% | 21.8% | 17.4% | 19.5% | 18.9% | 19.7% |
| Retailing | — | — | — | 0.1% | 1.2% | 1.6% |
| Pharmaceuticals | 2.1% | 2.0% | 1.4% | 1.5% | 1.4% | 1.6% |
| Healthcare Equipment & Supplies | — | 0.5% | 0.6% | 0.3% | 0.4% | 0.3% |
Allocation in Feb 2023change vs Jan 2023
- Pharmaceuticals & Biotechnology (19)76.8%▼ 1.4 pts
- Healthcare Services (7)19.7%▲ 0.8 pts
- Retailing (1)1.6%▲ 0.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Feb 2023
0.8%
▲ 0.1 pts vs Jan 2023
- Cash alone
- 0.8%
- cash and net receivables
- A year earlier
- 1.3%
- Feb 2022 · now ▼ 0.5 pts
- Last 12 months
- 0.3% – 2.2%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.